SPoW 12_22_18

R3 Bio has a bold idea for replacing lab animals: genetically-engineered whole organ systems that lack a brain. The long-term goal, says a cofounder, is to make human versions.

Companies hope that biometric age-verification tech in cartridges could put flavored vapes back in business. But it's unlikely to solve the real problems.

Joe Hogan, Align Technology’s plastics-nerd CEO, says you shouldn’t eat with your aligners and that you don’t need to wear your retainers every night.

From drones to missiles to submarines, the $30.5 billion defense startup wants to transform how the tools of war are made. It’s not all going as planned.

In this episode, the hosts discuss the fight between OpenAI and Elon Musk, the misuse of voter data, and Artemis II’s moonshot.

Your venomous serpent bites you, and the clock is ticking. America’s zookeepers—and a cooler full of rare antivenom—are your best chance of survival.

For months, lone vibe coder Rafael Concepcion has obsessively built tools to counter the federal immigration crackdown—pivoting as he’s been outmatched. He’s also lost his job and become a target.

Arm just confirmed the rumors: It’s producing its own chip for the first time. CEO Rene Haas explains why this won’t alienate the many chipmakers who license the company’s designs.

In this episode, we discuss Iran’s threats to target US tech firms, gear up for the midterm elections, and get a scene report from the Polymarket pop-up bar in DC.

In 2019, two Canadian brothers blew into Detroit with an irresistible pitch: For $50, almost anyone could become a property owner. When houses decayed and the city intervened, the blame games began.

Americans flocked to prediction markets last year. Now, it’s time to pay taxes on winnings. How do you do that? Great question.

Firewire makes the most innovative surfboards in the industry. This winter, I tried the Neutrino, Machado, and Revo Max to see if they're worth the hype.